Product Information

GEMFIBROZIL 600 MG TABLET is a generic product labeled by AvPAK, priced at $0.1045 per EA under NDC 50268035015. Its NADAC has been published 452 times since Nov 15, 2017.

FDA first approved this application on Jul 27, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GEMFIBROZIL 600 MG TABLET

Gemfibrozil
$0.1045per EA

Strength

600 mg/1

Manufacturer

AvPAK

NDC

50268035015

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GEMFIBROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA077836

FDA Approved

7/27/2006

TE Code

AB

On Market Since

7/10/2014

Pharmacological Classes

PPAR alpha
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists

Price Statistics

The NADAC for GEMFIBROZIL 600 MG TABLET has been published 452 times since Nov 15, 2017, and over the history we have for it it has risen 13.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1045 per EA
All-time high$0.1158 (Sep 11, 2019)
All-time low$0.0831 (Dec 20, 2017)
52-week high$0.1045
52-week low$0.1005
Median price$0.1045
Average price$0.1030
Largest weekly change-18.6% (Apr 17, 2024)
Weeks tracked452
Tracking sinceNov 15, 2017

Price History

1W

+0.1%

1M

+0.1%

3M

+0.8%

6M

+4.0%

1Y

+0.8%

3Y

-0.0%

5Y

-3.3%

All

+13.2%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GEMFIBROZIL 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by AvPAK, is $0.1045 per EA (NDC 50268035015), effective Aug 19, 2026.

How has the price of GEMFIBROZIL 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has risen 13.2%. It has been tracked across 452 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?

Since Nov 15, 2017, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0831 (Dec 20, 2017) to a high of $0.1158 (Sep 11, 2019), with a median of $0.1045 per EA.

Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 15% below GEMFIBROZIL 600 MG TABLET.

Who manufactures GEMFIBROZIL 600 MG TABLET?

GEMFIBROZIL 600 MG TABLET (NDC 50268035015) is labeled by AvPAK, and CMS classifies it as a generic product.